Article
Brain multi-omic Mendelian randomisation to identify novel drug targets for gliomagenesis
20 Nov 2024
Abstract excerpt
BACKGROUND: Genetic variants associated with molecular traits that are also associated with liability to glioma can provide causal evidence for the identification and prioritisation of drug targets. METHODS: We performed comprehensive two-sample Mendelian randomisation (Wald ratio and/or IVW) and colocalisation analyses of molecular traits on glioma. Instrumentable traits (QTLs P < 5 × 10-8) were identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
